VivoSeq
Other

Labor Pain

1

Pipeline Programs↗

4

Active Trials↗

0

Companies Involved↗

Labor Pain is an early-stage landscape with 1 program across 0 companies. 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved1

Bupivacaine Hydrochloride

Northwestern University

Analysis

Trial Status

6

clinical trials

Recruiting3 · 50%
Completed2 · 33%
Not yet recruiting1 · 17%

Clinical Trials

Trial Activity

6 trials

A Trial to Determine the Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief With a Lidocaine Test Dose
Recruiting·BBrigham and Women's Hospital·Approved·NCT06146842·120 enrolled
ED90 of Epidural Bupivacaine for the Initiation of Labor Analgesia: A Randomized Biased Coin Sequential Allocation Trial With a Lidocaine Test Dose
Recruiting·BBrigham and Women's Hospital·Approved·NCT05543694·120 enrolled
Efficacy of Ultrasound-Guided Versus Landmark-Based Epidural Labor Analgesia: A Randomized Clinical Trial.
Recruiting·UUniversity Medical Center Ho Chi Minh City (UMC)·Preclinical·NCT07669441·100 enrolled
Impact of Injected Volume on Programmed Intermittent Epidural Bolus Analgesia
Not yet recruiting·BBeth Israel Deaconess Medical Center·Approved·NCT07684365·70 enrolled
Oral Paracetamol as Preemptive Analgesia for Labor Pain
Completed·—·Phase 3·NCT01817829·100 enrolled
Effect of Hyoscine and Promethazine on Labor Pain
Completed·MMashhad University of Medical Sciences·Phase 2/3·NCT01644838·93 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)